Pseudomyxoma peritonei overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 10: Line 10:


==Pathophysiology==
==Pathophysiology==
 
The remarkable feature of pseudomyxoma peritonei is that this neoplastic, progressive process often arises from a seemingly benign or well differentiated primary tumor. Pseudomyxoma peritonei may be divided into two pathological subtypes which have aetiological and prognostic significance ( Peritoneal adenomucinosis and Peritoneal mucinous carcinoma).
==Causes==
==Causes==
 
Pseudomyxoma peritonei is caused by a pre-existing intraperitoneal mucinous neoplasm. The ''K-Ras'' and ''p53'' genes may be involved in the oncogenesis.
==Differentiating Pseudomyxoma peritonei from other Diseases==
==Differentiating Pseudomyxoma peritonei from other Diseases==
 
Pseudomyxoma peritonei must be differentiated from peritoneal carcinomatosis without mucinous ascites, peritoneal sarcomatosis, and [[peritonitis]].
==Epidemiology and Demographics==
==Epidemiology and Demographics==
 
The incidence of pseudomyxoma peritonei is approximately 0.5 to 1 per 100,000 individuals worldwide. Females are more commonly affected with pseudomyxoma peritonei than males. The median age at diagnosis is 50 years.
==Risk Factors==
==Risk Factors==
 
There are no established risk factors for pseudomyxoma peritonei.
==Natural History, Complications and Prognosis==
==Natural History, Complications and Prognosis==
 
If left untreated, patients with pseudomyxoma peritonei may progress to develop abdominal or pelvic pain, [[bloating]], [[abdominal distension]], [[weight change]], and [[infertility]].  Prognosis is generally good and the 10-year survival rate of patients with pseudomyxoma peritonei is approximately 63%.
==Diagnosis==
==Diagnosis==



Revision as of 20:04, 2 December 2015

Pseudomyxoma peritonei Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pseudomyxoma peritonei from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudomyxoma peritonei overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudomyxoma peritonei overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudomyxoma peritonei overview

CDC on Pseudomyxoma peritonei overview

Pseudomyxoma peritonei overview in the news

Blogs on Pseudomyxoma peritonei overview

Directions to Hospitals Treating Pseudomyxoma peritonei

Risk calculators and risk factors for Pseudomyxoma peritonei overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

Pseudomyxoma peritonei is an uncommon tumor known for its production of mucus in the abdominal cavity.[1] The tumor is not harmful by itself, but the mucus has no place to go inside the abdominal cavity. If left untreated, it will eventually build up to the point where it compresses vital structures: the colon, the liver, kidneys, etc.

Historical Perspective

The first case of pseudomyxoma peritonei was described by Carl F. Rokitansky in 1842.[2]

Pathophysiology

The remarkable feature of pseudomyxoma peritonei is that this neoplastic, progressive process often arises from a seemingly benign or well differentiated primary tumor. Pseudomyxoma peritonei may be divided into two pathological subtypes which have aetiological and prognostic significance ( Peritoneal adenomucinosis and Peritoneal mucinous carcinoma).

Causes

Pseudomyxoma peritonei is caused by a pre-existing intraperitoneal mucinous neoplasm. The K-Ras and p53 genes may be involved in the oncogenesis.

Differentiating Pseudomyxoma peritonei from other Diseases

Pseudomyxoma peritonei must be differentiated from peritoneal carcinomatosis without mucinous ascites, peritoneal sarcomatosis, and peritonitis.

Epidemiology and Demographics

The incidence of pseudomyxoma peritonei is approximately 0.5 to 1 per 100,000 individuals worldwide. Females are more commonly affected with pseudomyxoma peritonei than males. The median age at diagnosis is 50 years.

Risk Factors

There are no established risk factors for pseudomyxoma peritonei.

Natural History, Complications and Prognosis

If left untreated, patients with pseudomyxoma peritonei may progress to develop abdominal or pelvic pain, bloating, abdominal distension, weight change, and infertility. Prognosis is generally good and the 10-year survival rate of patients with pseudomyxoma peritonei is approximately 63%.

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Medical Therapy

Surgery

References

  1. Qu Z, Liu L (2006). "Management of pseudomyxoma peritonei". World J Gastroenterol. 12 (38): 6124–7. PMID 17036382.
  2. Pseudomyxoma peritonei. Wikipedia. https://en.wikipedia.org/wiki/Pseudomyxoma_peritonei. Accessed on December 2, 2015


Template:WikiDoc Sources